<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>AI in Healthcare on Expert LinkedIn</title>
    <link>https://expertlinked.in/subcategories/ai-in-healthcare/</link>
    <description>Recent content in AI in Healthcare on Expert LinkedIn</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <copyright>Copyright © ExpertLinkedIn</copyright>
    <lastBuildDate>Tue, 07 Apr 2026 00:00:00 +0800</lastBuildDate><atom:link href="https://expertlinked.in/subcategories/ai-in-healthcare/index.xml" rel="self" type="application/rss+xml" />
    
    <item>
      <title>AI Drug Discovery Solved the Easy Problem. Now Comes the Hard One.</title>
      <link>https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/</link>
      <pubDate>Tue, 07 Apr 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/</guid>
      <description>AI drug discovery&amp;rsquo;s 80-90% Phase I success rate is real. But Phase I mostly measures toxicity. The industry is betting billions on a revolution whose hardest proof is still outstanding.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-04-07-ai-drug-discovery-phase-three-test/featured.webp" />
    </item>
    
    <item>
      <title>The AI Agent Flood in Healthcare: HIMSS 2026 and the Validation We&#39;re Skipping</title>
      <link>https://expertlinked.in/posts/2026-03-12-healthcare-ai-agents-himss-validation-gap/</link>
      <pubDate>Thu, 12 Mar 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-03-12-healthcare-ai-agents-himss-validation-gap/</guid>
      <description>AI agents are proliferating across clinical settings faster than any validation framework can track — and a new BCBS study showing $663 million in AI-inflated billing is just the opening act.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-03-12-healthcare-ai-agents-himss-validation-gap/featured.webp" />
    </item>
    
    <item>
      <title>Claude for Healthcare: The Race Between AI Innovation and Preserving Human-Centered Medicine</title>
      <link>https://expertlinked.in/posts/2026-02-12-claude-healthcare-human-centered-ai/</link>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-02-12-claude-healthcare-human-centered-ai/</guid>
      <description>As major AI companies race into healthcare with sophisticated tools, the critical question isn&amp;rsquo;t just capability—it&amp;rsquo;s whether innovation can coexist with the human touch that defines quality care.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-02-12-claude-healthcare-human-centered-ai/featured.webp" />
    </item>
    
    <item>
      <title>Horizon 1000: When AI Meets Africa&#39;s Healthcare Crisis Head-On</title>
      <link>https://expertlinked.in/posts/2026-01-31-horizon-1000-ai-healthcare-africa/</link>
      <pubDate>Sat, 31 Jan 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-01-31-horizon-1000-ai-healthcare-africa/</guid>
      <description>Horizon 1000&amp;rsquo;s ambitious plan to bring AI to 1,000 African clinics by 2028 forces us to confront both AI&amp;rsquo;s potential and the structural inequities that threaten its success.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-01-31-horizon-1000-ai-healthcare-africa/featured.webp" />
    </item>
    
    <item>
      <title>When AI Therapy Meets Reality: The Regulatory Reckoning for Mental Health Chatbots</title>
      <link>https://expertlinked.in/posts/2026-01-22-ai-therapy-chatbots-regulatory-reckoning/</link>
      <pubDate>Thu, 22 Jan 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-01-22-ai-therapy-chatbots-regulatory-reckoning/</guid>
      <description>Slingshot AI&amp;rsquo;s UK withdrawal reveals the urgent need for clear regulatory frameworks governing AI mental health tools operating in the gray zone between wellness apps and medical devices.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-01-22-ai-therapy-chatbots-regulatory-reckoning/featured.webp" />
    </item>
    
    <item>
      <title>The AI Health Assistant Rush: Why ChatGPT Health and Claude for Healthcare Mark a Pivotal—and Precarious—Moment for Medicine</title>
      <link>https://expertlinked.in/posts/2026-01-13-ai-health-assistants-chatgpt-claude-promise-peril/</link>
      <pubDate>Tue, 13 Jan 2026 00:00:00 +0800</pubDate>
      
      <guid>https://expertlinked.in/posts/2026-01-13-ai-health-assistants-chatgpt-claude-promise-peril/</guid>
      <description>The January 2026 launches of ChatGPT Health and Claude for Healthcare represent both tremendous promise and serious peril for the future of AI in medicine.</description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://expertlinked.in/posts/2026-01-13-ai-health-assistants-chatgpt-claude-promise-peril/featured.webp" />
    </item>
    
  </channel>
</rss>
